The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-butyl-2-(phenylsulfonamido)benzoic acid ID: ALA425776
PubChem CID: 10246233
Max Phase: Preclinical
Molecular Formula: C17H19NO4S
Molecular Weight: 333.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCc1ccc(NS(=O)(=O)c2ccccc2)c(C(=O)O)c1
Standard InChI: InChI=1S/C17H19NO4S/c1-2-3-7-13-10-11-16(15(12-13)17(19)20)18-23(21,22)14-8-5-4-6-9-14/h4-6,8-12,18H,2-3,7H2,1H3,(H,19,20)
Standard InChI Key: GUFYXBDBRAROGG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
1.7031 -7.8023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7020 -8.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4163 -9.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1322 -8.6291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1295 -7.7989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4146 -7.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8425 -7.3839 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.5584 -7.7940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4206 -6.7984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2571 -6.7984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2715 -7.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9846 -7.7939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6971 -7.3797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6948 -6.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9740 -6.1439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2644 -6.5605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9850 -8.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2704 -9.0348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6994 -9.0349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4073 -6.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1237 -6.5471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1276 -7.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8440 -7.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
11 12 2 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 2 0
5 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
16 11 1 0
7 8 1 0
7 9 2 0
17 18 1 0
17 19 2 0
12 17 1 0
4 5 1 0
14 20 1 0
7 10 2 0
20 21 1 0
2 3 1 0
21 22 1 0
8 11 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.41Molecular Weight (Monoisotopic): 333.1035AlogP: 3.53#Rotatable Bonds: 7Polar Surface Area: 83.47Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.02CX Basic pKa: ┄CX LogP: 3.97CX LogD: 0.76Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.81Np Likeness Score: -1.11
References 1. Kawai M, BaMaung NY, Fidanze SD, Erickson SA, Tedrow JS, Sanders WJ, Vasudevan A, Park C, Hutchins C, Comess KM, Kalvin D, Wang J, Zhang Q, Lou P, Tucker-Garcia L, Bouska J, Bell RL, Lesniewski R, Henkin J, Sheppard GS.. (2006) Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties., 16 (13): [PMID:16632353 ] [10.1016/j.bmcl.2006.03.085 ]